Setjiadi, D., Delles, C., Kroon, A. A., Ressink, K., Bekers, O., Meex, S. J. R., Köhler, S., Kooman, J. P., Jansen, J. F. A., Brunner-La Rocca, H.-P., Wesselius, A., Houben, A. J. H. M., & van Greevenbroek, M. M. J. (2026). Characterization of participants with a disproportionate degree of hypertension-mediated organ damage: the Maastricht study. Journal of Hypertension, 44, 1329-1336. https://doi.org/10.1097/HJH.0000000000004265

ten Cate, V., Sulochana, H. R., ten Cate, H., & Nagy, M. (2026). Coagulation factor XI and cardiovascular disease: A complex, cardio-specific conundrum. Med, 7(2), Article 100995. https://doi.org/10.1016/j.medj.2025.100995

Andreotti, F., O'donoghue, M. L., & Ten Berg, J. (2026). The year in cardiovascular medicine 2025: the top 10 papers in thrombosis and antithrombotic therapy. European Heart Journal, 47(6), 662-665. https://doi.org/10.1093/eurheartj/ehaf1126

Von Hundelshausen, P., Siess, W., Duan, R., Bohnert, T., Hopkins, B. T., & Weber, C. (2026). Involvement of Btk in Cardiovascular Disease and Its Therapeutic Targeting. Circulation, 153(6), 435-456. https://doi.org/10.1161/CIRCULATIONAHA.125.076186

Galli, M., Pereira, N. L., Lennon, R. J., van den Broek, W. W. A., Claassens, D. M. F., Bergmeijer, T. O., Rosenberg, Y., Fazzini, L., Deneer, V. H. M., Murad, M. H., Farkouh, M. E., Rihal, C., ten Berg, J., & Angiolillo, D. J. (2026). Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome. JACC. Cardiovascular interventions, 19(3), 283-296. https://doi.org/10.1016/j.jcin.2025.11.029

Nandy, M., Ghosh, U., Ganar, K. A., Ippel, H., Dijkgraaf, I., & Deshpande, S. (2026). pH-Tunable Material Properties of Glycine-Rich Condensates from Tick Bioadhesive. Advanced Functional Materials, 36(10), Article e15418. https://doi.org/10.1002/adfm.202515418

Galli, M., Ten Berg, J., Valgimigli, M., Capodanno, D., Gragnano, F., Kimura, T., Bhatt, D. L., Gibson, C. M., Mehran, R., & Angiolillo, D. J. (2026). Aspirin or P2Y₁₂ inhibitor monotherapy in atherosclerotic cardiovascular disease?European Heart Journal, 47(5), 558-573. Article ehaf718. https://doi.org/10.1093/eurheartj/ehaf718

Nagy, M., Gomes, T., Van Oerle, R., Hacking, T. M., Magdelijns, F. J. H., Henskens, Y. M. C., Reitsma, P., Short, G., Spronk, H. M. H., & Verhoef, D. (2026). Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001. Research and practice in thrombosis and haemostasis, 10(2), Article e103375. https://doi.org/10.1016/j.rpth.2026.103375

Magdelijns, F. J. H., de Jong, M. J., Winckers, K., Braeken, D. C. W., & Cate, H. T. (2026). Frail older patients and direct oral anticoagulants: trouble in paradise?Journal of Thrombosis and Haemostasis, 24(2), 781-783. https://doi.org/10.1016/j.jtha.2025.10.034

Li, Y., Leberzammer, J., Blanchet, X., Duan, R., Lacy, M., Triantafyllidou, V., Eckardt, V., Briem, E., Jung, A. S., Su, R., Guerra, J., Jansen, Y., Hristov, M., Enard, W., Bernhagen, J., Weber, C., Atzler, D., Bartelt, A., Doring, Y., ... Von Hundelshausen, P. (2026). Galectin-1 induces macrophage immunometabolic reprogramming, modulates T cell immunity and attenuates atherosclerotic plaque formation. Atherosclerosis, 413, Article 120608. https://doi.org/10.1016/j.atherosclerosis.2025.120608

Biguzzi, E., Winckers, K., Hackeng, T. M., Rosendaal, F. R., & Vlieg, A. V. H. (2026). Recurrent venous thromboembolism: association with thrombin generation and d-dimer. Research and practice in thrombosis and haemostasis, 10(2), Article 103391. https://doi.org/10.1016/j.rpth.2026.103391

Sivanesan, S., Gasecka, A., Van Der Sangen, N. M. R., Van Den Broek, W. W. A., Azzahhafi, J., Yin, D. R. P. P. C. P., Van De Pol, Q. Y. F., Walhout, R. J., Gin, M. T. J., Pisters, R., Nicastia, D. M., de Roest, G. J., Vlachojannis, G. J., van Bommel, R. J., Kikkert, W. J., Henriques, J. P. S., ten Berg, J. M., & Appelman, Y. (2026). Sex differences in the presentation and management of acute coronary syndrome patients: Insights from the FORCE-ACS registry. IJC Heart and Vasculature, 62, Article 101849. https://doi.org/10.1016/j.ijcha.2025.101849

Kempers, E. K., Acampo-de Jong, M. J. J., ten Cate, H., De Caterina, R., & Kruip, M. J. H. A. (2026). Timeless therapeutics: cardiac indications for vitamin K antagonists in clinical practice. Heart. https://doi.org/10.1136/heartjnl-2024-324551

Iding, A. F. J., Hupperetz, R. D., Brans, R. J. B., ten Cate, H., van Twist, D. J. L., & ten Cate-Hoek, A. J. (2026). Additional oxerutin therapy to promote deep vein thrombus resolution (RESOLVE-DVT): a randomized controlled pilot trial. Journal of Thrombosis and Haemostasis, 24(2), 644-653. https://doi.org/10.1016/j.jtha.2025.10.018

Aynekulu Mersha, D. G., Lopuhaä, B., Gietema, H. A., Smit, J., Wind, A. E., Hulshof, A. M., Daenen, K., Khyali, J., van Bussel, B. C. T., van Oosterhout, M. F. M., Moeniralam, H. S., Kempers, E. K., Kruip, M. J. H. A., Klok, F. A., Dalm, V. A. S. H., Endeman, H., Van Gorp, E. C. M., Dik, W. A., von der Thüsen, J. H., & Juffermans, N. P. (2026). In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome. Journal of Thrombosis and Haemostasis, 24(2), 662-671. https://doi.org/10.1016/j.jtha.2025.10.021

de Jong, M. J., Brys, A. D. H., Braeken, D., Pisters, R., Janssen, D. J. A., Altintas, S., Robben, S. H. M., Nicolai, S., Eurlings, C., Zwietering, A., De Jonghe, M., Vaes, B., De Backer, T., Grymonprez, M., Joosten, H., ten Cate, H., Winckers, K., & Magdelijns, F. J. H. (2026). Healthcare professionals' perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire. BMC Geriatrics, 26(1), Article 418. https://doi.org/10.1186/s12877-026-06972-3

Halkes, C. J. M., Koster, E. A. S., Bogers, E. J. M., Heubel-Moenen, F. C. J. I., Daenen, L. G. M., Klein, S. K., Langemeijer, S. M. C., Nur, E., Raaijmakers, M. H. G., Snijders, T. J. F., Tjon, J. M. L., & De Wreede, L. C. (2026). Anti-thymocyte globulin-based treatment frequently leads to enduring treatment success in both old and young adult patients with aplastic anaemia: a real-world analysis from the Dutch aplastic anaemia registry. Annals of Hematology, 105(2), Article 51. https://doi.org/10.1007/s00277-026-06743-5

Mohanta, S. K., Peng, L., Li, Y., Lu, S., Sun, T., Carnevale, L., Perrotta, M., Ma, Z., Forstera, B., Stanic, K., Zhang, C., Zhang, X., Szczepaniak, P., Bianchini, M., Saeed, B. R., Carnevale, R., Hu, D., Nosalski, R., Pallante, F., ... Habenicht, A. J. R. (2026). Author Correction: Neuroimmune cardiovascular interfaces control atherosclerosis. Nature, 649, E7. https://doi.org/10.1038/s41586-025-10043-9

Imkamp, M. S. V., Prudente, V. C. G., Aydeniz, E., van Rosmalen, F., de Jongh, S., van Kuijk, S. M. J., Seiler, C., Schellens, J., Driessen, M., Heines, S. J. H., van der Horst, I. C. C., Bergmans, D. C. J. J., Wee, L., & van Bussel, B. C. T. (2026). Vulnerabilities of feature clustering in EIT radiomics. Computers in Biology and Medicine, 201, Article 111438. https://doi.org/10.1016/j.compbiomed.2025.111438

Vojinovic, U., Schoenmakers, T., Deneer, R., Leers, M. P. G., Van Rosmalen, F., Gorissen, S. H. M., Van De Venne, W. P. H. G., Van Mook, W. N. K. A., Van Bussel, B. C. T., Savelkoul, P., Van Loo, I. H. M., Wolffs, P. F. G., & CoLaIC-consortium (2026). Earlier de-isolation of SARS-CoV-2-infected ICU patients using a novel viability PCR: a prospective cohort study. Microbiology spectrum, 14(1), 1-12. Article e01140-25. https://doi.org/10.1128/spectrum.01140-25

Jaakonmäki, N., Helin, T., Szanto, T., Zedde, M., Sarkanen, T., Martinez-Majander, N., Sinisalo, J., Junttola, U., Redfors, P., von Sarnowski, B., Waje-Andreassen, U., Ylikotila, P., Yesilot, N., Ryliskiene, K., Tulkki, L., Amaya Pascasio, L., Licenik, R., Ferdinand, P., Gerdts, E., ... SECRETO Study Group (2026). Anti-beta2-glycoprotein I IgG antibodies are associated with early-onset cryptogenic ischemic stroke. European Stroke Journal, 11(1), Article 23969873251351207. https://doi.org/10.1177/23969873251351207

Visser, C., Kempers, E. K., Seelig, J., Chen, Q., Adriaansen, H. J., Beinema, M. J., ten Cate-Hoek, A., Faber, L. M., Klok, F. A., Leebeek, F. W. G., van de Leur, S. J. C. M., Nierman, M. C., Pisters, R., Schindhelm, R. K., Stork, A. D. M., Wiersma, N. M., De Caterina, R., Cannegieter, S. C., Hemels, M. E. W., ... Kruip, M. J. H. A. (2026). Anticoagulation Therapeutic Ranges and Clinical Outcomes in Patients with a Mechanical Heart Valve Treated with Vitamin K Antagonists-a Nationwide Linked-data Dutch Study. Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1055/a-2773-5810

Auditeau, C., Bianchini, E. P., Peyron, I., Ruty, A., Saenjamsai, P., Khamari, M., Hackeng, T. M., Christophe, O. D., Denis, C. V., Borgel, D., Lenting, P. J., & Saller, F. (2026). Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders. Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1055/a-2894-0856

Evans, B. R., Schulz, J., Triantafyllidou, V., Yerly, A., Thakur, M., Angliker, N., Siegrist, M., Jansen, Y., Yan, Y., Maas, S. L., Gold, C., Farina, F. M., Bayer, B., Bartelt, A., Weber, C., Wettich, J., Maegdefessel, L., Sachs, N., Schindewolf, M., ... Doering, Y. (2026). ChemR23 prevents phenotypic switching of vascular smooth muscle cells into macrophage-like foam cells in atherosclerosis. Cardiovascular Research, 122(2), 195-213. https://doi.org/10.1093/cvr/cvaf258

Thakur, M., Quillard, T., Angliker, N., Siegrist, M., Jansen, Y., Yan, Y., Wollenhaupt, J., Goettsch, C., Maegdefessel, L., Sachs, N., Schindewolf, M., Kotelis, D., Noels, H., & Döring, Y. (2026). DDR1 Regulates Femoral Arterial Calcification in Lower-Extremity Artery Disease Through NF-Kappa B Activation. Acta Physiologica, 242(1), Article e70146. https://doi.org/10.1111/apha.70146

Mikolajetz, D., Kalim, S., Noels, H., Wu, Z., Jankowski, V., Jankowski, J., & de la Puente-secades, S. (2026). Impact of amino acid supplementation on cardiovascular and chronic kidney diseases: a systematic review. Cardiovascular Research, 122(2), 178-194. https://doi.org/10.1093/cvr/cvag007

Meenks, S. D., Bouman, H., Karapinar, F., van Bussel, B. C. T., Janssen, P. K. C., & de Boer, D. (2026). Mass Spectrometric Characterization of Flucloxacillin Binding to Serum Albumin in Hospitalized Patients With Hypoalbuminemia: An Observational Pilot Study. Therapeutic Drug Monitoring. Advance online publication. https://doi.org/10.1097/FTD.0000000000001504

D'alessandro, E., Scaf, B., Opacic, D., van Hunnik, A., Sobota, V., Kuiper, M., Viola, M., Hutschalik, T., Langione, M., Pioner, J. M., Munts, C., Simons, J., Winters, J., Isaacs, A., Heitmeier, S., Stoll, M., van Oerle, R., Ten Cate, H., Spronk, H. M. H., ... Schotten, U. (2026). Rivaroxaban Treatment Prevents Atrial Myocyte Hypertrophy in Goats with Persistent Atrial Fibrillation by Inhibition of Protease-Activated Receptor-1. Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1055/a-2761-6106

Buhre, W., Diaz-Cambronero, O., Schaefer, S., Novacek, M., Domingo, M. S., Stessel, B., Rodriguez-Perez, A., Richter, T., Rohe, G., Cholley, B., Gruenewald, M., Kuiper, G., Jaber, S., De Korte, D., Belda, J., De Abreu, M. G., Baronica, R., Scheeren, T., Ferrando-Ortola, C., ... Westphal, M. (2026). Safety and efficacy of 6% hydroxyethyl starch in patients undergoing major surgery: The randomised controlled PHOENICS trial. European Journal of Anaesthesiology, 43(1), 1-10. https://doi.org/10.1097/EJA.0000000000002307

Denessen, E. J. S., Vroemen, W. H. M., Jansen, T. G. F., Henskens, Y. M. C., Bekers, O., & Mingels, A. M. A. (2026). The effect of anticoagulation medication on cardiac troponin T degradation: a proof of principle study. Journal of Laboratory and Precision Medicine, 11, Article 33. https://doi.org/10.21037/jlpm-2026-1-0013

Bhargava, S., Rao, Z., Vanholder, R., Tacke, F., Noels, H., Jankowski, V., Hermann, J., & Jankowski, J. (2026). The impact of gut-liver-derived mediators on the organ crosstalk with brain, heart, and kidney: A systematic review. Molecular Metabolism, 103, Article 102295. https://doi.org/10.1016/j.molmet.2025.102295

Weber, C., Rigby, A., & Lip, G. Y. H. (2026). Thrombosis and Haemostasis 2025 Editors' Choice. Thrombosis and Haemostasis, 126(1), 107-111. https://doi.org/10.1055/a-2763-7391

Lip, G. Y. H., Rigby, A., & Weber, C. (2026). Welcoming 2026: A Year of Innovation, Integrity, and Global Connection. Thrombosis and Haemostasis, 126(01), 1-4. https://doi.org/10.1055/a-2765-9724

Schnidrig, K., Thakur, M., Tuleja, A., Bernhard, S. M., Noels, H., Kotelis, D., Schindewolf, M., & Doring, Y. (2026). Implications of inflammation and sex in lower extremity arterial disease. European Journal of Clinical Investigation, 56(1), Article e70144. https://doi.org/10.1111/eci.70144

Meenks, S., Aydeniz, E., van Bussel, B., le Noble, J., & Janssen, P. (2026). The association between unbound ceftriaxone area under the curve in the first 24 treatment hours and longitudinal C-reactive protein response in critically ill patients: an observational study. Intensive Care Medicine, 52(1), 185-187. https://doi.org/10.1007/s00134-025-08138-y

Wang, S. J., Deneer, R., Schoenmakers, T., Mestrum, S. G. C., Henskens, Y. M. C., Bekers, O., Hopman, A. H. N., Ramaekers, F. C. S., & Leers, M. P. G. (2026). A Robust Computational Workflow Utilizing Generalized Least Squares (GLS) and Generalized Estimating Equations (GEE-GLM) for Longitudinal Flow Cytometry Maturation Data Analysis. Cytometry Part A. Advance online publication. https://doi.org/10.1002/cyto.a.70061

Hupperetz, R. D., Iding, A. F. J., van Laanen, J., Brans, R., Notten, P., Asiong, J., Wikkeling, O. R. M., Vleming, L.-J., Jacobs, E. M. G., Koster, A., Wittens, C., ten Cate, H., & ten Cate-Hoek, A. J. (2026). Biomarkers in Relation to Patency, Popliteal Reflux, and Post-thrombotic Syndrome: A Subanalysis of the Ultrasound-accelerated Catheter-directed Thrombolysis versus Anticoagulation for the Prevention of Post-thrombotic Syndrome Trial. Thrombosis and Haemostasis. Advance online publication. https://doi.org/10.1055/a-2794-5116

Voorhout, L. J., Verburg, A., Pisters, R., Ten Berg, J. M., & Hemels, M. E. W. (2026). Clinical implications of the interaction between metabolic risk factors, coronary artery disease and atrial fibrillation. Future Cardiology, 22(1), 57-63. https://doi.org/10.1080/14796678.2025.2603066

van der Walle, K., Denig, P., Boerman, T., Magdelijns, F. J. H., Nielen, J. T. H., & Karapinar-Carkit, F. (2026). Creating Awareness of preScribing Cascades and Managing Adverse Drug Effects (CASC-ADE) Tool: Appraisal by Future End Users. Drugs & Aging. Advance online publication. https://doi.org/10.1007/s40266-026-01334-5

Cate-Hoek, A. J. T., & Rocca, B. (2026). Glycoprotein IIb/IIIa Blockade: Ready to CELEBRATE a New Dawn?European Cardiology Review, 21, 1-2. Article e08. https://doi.org/10.15420/ecr.2025.98

Chiusolo, S., Verburg, A., Morizzo, C., van Schaik, R. H. N., Matic, M., Coenen, M. J. H., Maeng, M., ten Berg, J., & De Caterina, R. (2026). Impact of CYP2C19 loss-of-function variants on outcomes in atrial fibrillation patients undergoing percutaneous coronary intervention: rationale and study design of the WOEST-3 genetic substudy. Bleeding, thrombosis and vascular biology., 5(3), Article 421. https://doi.org/10.4081/btvb.2026.421

MacArthur, R. B., Rikken, S. A. O. F., Vootukuri, S. R., Coller, B. S., Gibson, C. M., Granger, C. B., Montalescot, G., Ten Berg, J. M., Ducharme, M. P., & Hof, A. W. J. V. (2026). Mass balance and metabolite profiling of <SUP>14</SUP>C-Zalunfiban in humans following single-dose subcutaneous administration. Xenobiotica, 56(1), 1-10. https://doi.org/10.1080/00498254.2025.2597225

Nieuwenstein, T., Stoffer, I. P., Hellenbrand, D. L. S., Mathot, R. A. A., van Pelt, L. J., Pequeriaux, N. C. V., van de Kerkhof, D., Kuijper, P. H. M., Zant, J. C., Garnier, D. A. J., Schindhelm, R. K., Hamer, H. M., van Duijnhoven, H. L. P., Bosman, M. C. J., Jeninga, E. H., de Kok, J. B., Schellings, M. W. M., Waals-Prinzen, L., Rijpma, S. R., ... Stroobants, A. K. (2026). Reagent-specific anti-Xa DOAC safety cutoffs can be established using multiple LMWH-calibrated anti-Xa assays. Clinical Chemistry and Laboratory Medicine. Advance online publication. https://doi.org/10.1515/cclm-2026-0026

De Luca, G., Algowhary, M., Uguz, B., C Oliveira, D., Ganyukov, V., Zimbakov, Z., Cercek, M., Jensen, L. O., Huan Loh, P., Calmac, L., Roura I Ferrer, G., Quadros, A., Malewski, M., Di Uccio, F. S., Von Birgelen, C., Versaci, F., Ten Berg, J., Casella, G., Wong Sung Lung, A., ... Et al. (2026). Validation of the Zwolle Risk Score in STEMI Patients Undergoing Primary PCI: Insights from the ISCAS-STEMI COVID-19 Registry. Current vascular pharmacology, 24(1), 68-75. https://doi.org/10.2174/0115701611335913250408214530

Wu, Y., Van Dellen, F., Ten Cate, H., Henskens, Y., & Winckers, K. (2025). Challenges in diagnosing sticky platelet syndrome using light transmission aggregometry: a scoping review. Platelets, 36(1), Article 2560380. https://doi.org/10.1080/09537104.2025.2560380

van't Hof, A. W. J., Gibson, C. M., Rikken, S. A. O. F., Januzzi, J. L., Granger, C. B., van Beurden, A., Rasoul, S., Ruiters, L., Vainer, J., Verburg, A., Arslan, F., Jukema, J. W., Durieux, M., Polad, J., van Vliet, R., van den Branden, B. J. L., Magro, M., Remkes, W., Beelen, J., ... CELEBRATE Trial Investigators (2025). Zalunfiban at First Medical Contact for ST-Elevation Myocardial Infarction. NEJM Evidence, 5(1). https://doi.org/10.1056/EVIDoa2500268

Aroca-Crevillen, A., Martin-Salamanca, S., Torres, L. S., Crainiciuc, G., Sicilia, J., Penaloza-Martinez, E., Rosillo, N., Molina-Moreno, M., Adrover, J. M., Rubio-Ponce, A., Vicanolo, T., Liu, X., Wichapong, K., Nunez, V., Balabanian, K., Bachelerie, F., Sancho, D., Casanova-Acebes, M., Ortiz-Perez, J. T., ... Hidalgo, A. (2025). A circadian checkpoint relocates neutrophils to minimize injury. Journal of Experimental Medicine, 223(2), Article e20250240. https://doi.org/10.1084/jem.20250240

Vicente-Steijn, R., Spiegelenberg, J., Rijpma, S. R., Henskens, Y. M. C., Leentjens, J., Ponjee, G., & Stroobants, A. (2025). A scoping review protocol on active drug monitoring of direct oral anticoagulants on vulnerable patient groups to detect potential adverse risks. Thrombosis Update, 21, Article 100223. https://doi.org/10.1016/j.tru.2025.100223